Sasano H - Search Results

1

DLL3 as an Emerging Target for the Treatment of Neuroendocrine Neoplasms.

Yao J, Bergsland E, Aggarwal R, Aparicio A, Beltran H, Crabtree JS, Hann CL, Ibrahim T, Byers LA, Sasano H, Umejiego J, Pavel M. Yao J, et al. Among authors: sasano h. Oncologist. 2022 Nov 3;27(11):940-951. doi: 10.1093/oncolo/oyac161. Oncologist. 2022. PMID: 35983951 Free PMC article. Review.

2

mTOR expression and activity patterns in gastroenteropancreatic neuroendocrine tumours.

Kasajima A, Pavel M, Darb-Esfahani S, Noske A, Stenzinger A, Sasano H, Dietel M, Denkert C, Röcken C, Wiedenmann B, Weichert W. Kasajima A, et al. Among authors: sasano h. Endocr Relat Cancer. 2011 Jan 13;18(1):181-92. doi: 10.1677/ERC-10-0126. Print 2011 Feb. Endocr Relat Cancer. 2011. PMID: 21159731

3

[Changes in the concept of neuroendocrine tumor].

Sasano H. Sasano H. Gan To Kagaku Ryoho. 2009 Oct;36(10):1602-5. Gan To Kagaku Ryoho. 2009. PMID: 19838016 Japanese.

4

[Recent advances in gastroenteropancreatic neuroendocrine tumor pathology].

Sasano H, Kasajima A. Sasano H, et al. Gan To Kagaku Ryoho. 2013 Jul;40(7):833-7. Gan To Kagaku Ryoho. 2013. PMID: 23863722 Japanese.

5

Pathology diagnosis of pancreatic neuroendocrine tumors.

Kasajima A, Yazdani S, Sasano H. Kasajima A, et al. Among authors: sasano h. J Hepatobiliary Pancreat Sci. 2015 Aug;22(8):586-93. doi: 10.1002/jhbp.208. Epub 2015 Feb 2. J Hepatobiliary Pancreat Sci. 2015. PMID: 25641911 Review.

6

Classification and Prognostic Stratification of Bronchopulmonary Neuroendocrine Neoplasms.

Oka N, Kasajima A, Konukiewitz B, Sakurada A, Okada Y, Kameya T, Weichert W, Ishikawa Y, Suzuki H, Sasano H, Klöppel G. Oka N, et al. Among authors: sasano h. Neuroendocrinology. 2020;110(5):393-403. doi: 10.1159/000502776. Epub 2019 Aug 19. Neuroendocrinology. 2020. PMID: 31422400

7

Novel classification based on immunohistochemistry combined with hierarchical clustering analysis in non-functioning neuroendocrine tumor patients.

Iida S, Miki Y, Ono K, Akahira J, Suzuki T, Ishida K, Watanabe M, Sasano H. Iida S, et al. Among authors: sasano h. Cancer Sci. 2010 Oct;101(10):2278-85. doi: 10.1111/j.1349-7006.2010.01657.x. Epub 2010 Aug 2. Cancer Sci. 2010. PMID: 20682006 Free article.

8

Synergistic anti-tumor effects of RAD001 with MEK inhibitors in neuroendocrine tumors: a potential mechanism of therapeutic limitation of mTOR inhibitor.

Iida S, Miki Y, Ono K, Akahira J, Nakamura Y, Suzuki T, Sasano H. Iida S, et al. Among authors: sasano h. Mol Cell Endocrinol. 2012 Mar 5;350(1):99-106. doi: 10.1016/j.mce.2011.11.024. Epub 2011 Dec 8. Mol Cell Endocrinol. 2012. PMID: 22178087

9

Progesterone Receptor Isoforms A and B in Pancreatic Neuroendocrine Tumor.

Yazdani S, Kasajima A, Ogata H, Felizola SJ, Nakamura Y, Onodera Y, Watanabe M, Motoi F, Unno M, Sasano H. Yazdani S, et al. Among authors: sasano h. Neuroendocrinology. 2015;101(4):309-20. doi: 10.1159/000381455. Epub 2015 Mar 16. Neuroendocrinology. 2015. PMID: 25791399

10

The Risk Factors for Metastasis in Non-Ampullary Duodenal Neuroendocrine Tumors Measuring 20 mm or Less in Diameter.

Hatta W, Koike T, Iijima K, Asanuma K, Asano N, Musha H, Inomata Y, Sano T, Endo H, Ikehata A, Horii T, Ohyauchi M, Yokosawa S, Kasajima A, Fujishima F, Sasano H, Nakaya N, Nakamura T, Shimosegawa T. Hatta W, et al. Among authors: sasano h. Digestion. 2017;95(3):201-209. doi: 10.1159/000459619. Epub 2017 Mar 18. Digestion. 2017. PMID: 28315861

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,363 results

Search Page